Simultaneous Quantification of 1,N2-Propano-2′-deoxyguanosine Adducts Derived from Acrolein and Crotonaldehyde in Human Placenta and Leukocytes by Isotope Dilution Nanoflow LC Nanospray Ionization Tandem Mass Spectrometry
- 9 November 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 81 (23), 9812-9818
- https://doi.org/10.1021/ac9019472
Abstract
Humans are exposed to acrolein and crotonaldehyde due to environmental pollution and endogenous lipid peroxidation. These aldehydes react with the 2′-deoxyguanosine moiety of DNA, forming the exocyclic 1,N2-propano-2′-deoxyguanosine adducts AdG and CdG. These adducts are mutagenic lesions, and they play an important role in cancer and neurodegenerative diseases. In this study, a highly sensitive and quantitative assay was developed for simultaneous detection and quantification of AdG and CdG isomers in human placenta and leukocyte DNA by isotope dilution nanoflow LC with nanospray ionization tandem mass spectrometry (nanoLC-NSI/MS/MS). The on-column detection limits (S/N ≥ 3) of AdG and CdG were 15 and 8.9 amol, respectively. The quantification limits of AdG and CdG for the entire assay were 619 and 297 amol, respectively, corresponding to 9.8 and 4.7 adducts in 109 normal nucleotides, respectively, starting with 20 μg of DNA. Different enzyme hydrolysis methods were compared, and the optimal hydrolysis conditions were employed for the assay. Levels of AdG and CdG in human placental DNA (20 μg) were 108 and 26 in 108 normal nucleotides, respectively, with the respective relative standard deviation (RSD) of 2.6% and 3.1% (n = 3). Levels of AdG and CdG in 9 human leukocyte DNA samples were 78 ± 23 (mean ± SD) and 6.2 ± 3.8 (mean ± SD) in 108 normal nucleotides, respectively, starting from 30 μg of DNA. Using this assay, only 4−6 μg of DNA sample was subjected to this nanoLC-NSI/MS/MS system for analysis. Only 1−1.5 mL of blood is needed for measuring AdG and CdG levels in leukocyte DNA. Thus, it is clinically feasible using this highly sensitive assay to investigate the potential of using these adducts as noninvasive biomarkers for DNA damage resulting from acrolein and crotonaldehyde and to study their roles in cancer development and prevention.Keywords
This publication has 25 references indexed in Scilit:
- Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repairProceedings of the National Academy of Sciences, 2006
- Genotoxicity of acetaldehyde- and crotonaldehyde-induced 1,N2-propanodeoxyguanosine DNA adducts in human cellsMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2006
- Mammalian cell mutagenesis of the DNA adducts of vinyl chloride and crotonaldehydeEnvironmental and Molecular Mutagenesis, 2005
- Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditionsToxicology, 2003
- Mutagenesis by Acrolein-Derived Propanodeoxyguanosine Adducts in Human CellsBiochemistry, 2002
- Identification of DNA Adducts of AcetaldehydeChemical Research in Toxicology, 2000
- Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adductsCarcinogenesis: Integrative Cancer Research, 1996
- Crotonaldehyde is mutagenic in Salmonella typhimurium TA100Environmental and Molecular Mutagenesis, 1989
- Naturally occurring carbonyl compounds are mutagens Salmonella tester strain TA104Mutation Research, 1985
- AcroleinMutation Research/Reviews in Genetic Toxicology, 1978